Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | b-NGF | 81.0 | 58 | ||||
| RA1931 | IKK16 | 2.0 | uM | 1 | b-NGF | 38.5 | 68 | ||||
| N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | b-NGF | 35.5 | 56 | ||||
| N2586 | IKK16 | 2.0 | uM | 1 | b-NGF | 24.0 | 53 | ||||
| RA1869 | Tofacitinib | 0.3 | uM | 1 | b-NGF | 53.0 | 67 | ||||
| RA1869 | 1 | b-NGF | 40.5 | 46 | |||||||
| N2759 | Tofacitinib | 0.3 | uM | 1 | b-NGF | 36.0 | 49 | ||||
| N2759 | 1 | b-NGF | 29.0 | 45 | |||||||
| RA1931 | Tofacitinib | 0.3 | uM | 1 | b-NGF | 101.0 | 40 | ||||
| RA1931 | 1 | b-NGF | 43.0 | 48 | |||||||
| N2586 | Tofacitinib | 0.3 | uM | 1 | b-NGF | 35.0 | 37 | ||||
| N2586 | 1 | b-NGF | 41.0 | 38 | |||||||
| 0 | b-NGF | 13.5 | 36 | ||||||||
| 0 | b-NGF | 15.0 | 63 | ||||||||
| 0 | b-NGF | 13.0 | 66 | ||||||||
| 0 | b-NGF | 15.0 | 33 | ||||||||
| 0 | b-NGF | 16.0 | 39 | ||||||||
| 0 | b-NGF | 13.0 | 36 | ||||||||
| RA2159 | 2 | b-NGF | 38.0 | 54 | |||||||
| N2645 | 2 | b-NGF | 399.0 | 67 | |||||||
| RA2708 | 2 | b-NGF | 46.0 | 47 | |||||||
| RA2159 | JNK-IN-8 | 3.0 | uM | 2 | b-NGF | 34.5 | 54 | ||||
| RA2159 | PH-797804 | 0.6 | uM | 2 | b-NGF | 35.0 | 50 | ||||
| N2645 | JNK-IN-8 | 3.0 | uM | 2 | b-NGF | 155.0 | 35 | ||||
| N2645 | PH-797804 | 0.6 | uM | 2 | b-NGF | 196.0 | 51 |